| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.015 | 0.7 |